Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
Total: 100 #61
CompanyAmalgamated Financial Corp.
IndustryBanks - Regional
Market Cap681.68MEPS (ttm)2.05
P/E10.92EPS this Y13.60%
Forward P/E7.67EPS next Y17.46%
PEG-EPS past 5Y38.30%
P/S3.36EPS next 5Y-
P/B1.32EPS Q/Q16.50%
Dividend1.79%Sales Q/Q16.40%
Insider Own26.20%Inst Own52.50%
Insider Trans-0.61%Inst Trans0.39%
Short Float0.67%EarningsJul 28/b
Analyst Recom2.30Target Price27.00
Avg Volume124.80K52W Range13.48 - 25.03
Aug-11-22 07:30AMAmalgamated Bank Announces $15 million Loan for Decarbonization and Climate Resilience Initiatives GlobeNewswire
Jul-31-22 08:20AMAmalgamated Financial's (NASDAQ:AMAL) Shareholders Will Receive A Bigger Dividend Than Last Year Simply Wall St.
Jul-28-22 06:25AMAmalgamated Financial Corp. Reports Record Second Quarter 2022 Financial Results GlobeNewswire
Jul-27-22 04:15PMAmalgamated Financial Corp. Announces 25% Quarterly Dividend Increase GlobeNewswire
Jul-27-22 04:10PMAmalgamated Financial Corp. Appoints Meredith Miller to its Board of Directors GlobeNewswire
Jul-14-22 04:10PMAmalgamated Financial Corp. Announces Second Quarter 2022 Earnings Conference Call GlobeNewswire
Jul-12-22 11:04AM7 Bank Stocks to Buy on the Dip InvestorPlace
Jun-24-22 04:46AMZacks.com featured highlights PBF Energy, Quanex Building Products, Amalgamated Financial and Huron Consulting Zacks
Jun-23-22 08:03AM4 Stocks Trading Near 52-Week High That Can Climb Further Zacks
May-10-22 08:16AMZacks.com featured highlights include Mercer International, Solaris Oilfield Infrastructure, and Amalgamated Financial Zacks
Amalgamated Financial Corp. operates as the bank holding company for Amalgamated Bank that provides commercial and retail banking, investment management, and trust and custody services for commercial and retail customers in the United States. The company accepts various deposit products, including non-interest bearing accounts, interest-bearing demand products, savings accounts, money market accounts, NOW accounts, and certificates of deposit. It also provides various commercial loans comprising commercial and industrial, multifamily mortgage, and commercial real estate loans; and retail loans, such as residential real estate, and consumer and other loans. In addition, the company offers online banking, bill payment, online cash management, and safe deposit box rental services; debit and ATM cards; and trust, custody, and investment management services comprising asset safekeeping, corporate actions, income collections, proxy, account transition, asset transfers, and conversion management services. Further, it provides investment products, such as equity, fixed-income, real estate, and alternative investment products; and brokerage, asset management, and insurance products. The company operates through its three branch offices across New York City, one branch office in Washington, D.C., one branch office in San Francisco, one commercial office in Boston, and digital banking platform. Amalgamated Financial Corp. was founded in 1923 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mark FinserDirectorSep 06Sale22.095,000110,44316,381Sep 07 04:30 PM
Mark FinserDirectorSep 02Sale22.345,000111,69219,243Sep 02 04:30 PM
Mark FinserDirectorSep 01Sale22.145,000110,72424,243Sep 02 04:30 PM
Amalgamated Financial Corp.Workers UnitedAug 11Buy23.6812,669300,0008,003,019Aug 15 06:10 PM
Darby JasonSenior Executive VP and CFOAug 01Option Exercise14.6518,920277,17818,920Aug 03 04:55 PM
TickerQRVO [NASD, S&P 500]
CompanyQorvo, Inc.
Market Cap9.29BEPS (ttm)7.39
P/E12.19EPS this Y46.50%
Forward P/E8.70EPS next Y26.57%
PEG1.22EPS past 5Y135.90%
P/S2.03EPS next 5Y10.00%
P/B2.20EPS Q/Q-74.10%
Dividend-Sales Q/Q-6.80%
Insider Own0.50%Inst Own91.20%
Insider Trans-5.53%Inst Trans-2.31%
Short Float2.45%EarningsAug 03/a
Analyst Recom2.70Target Price125.52
Avg Volume1.31M52W Range87.05 - 183.55
Sep-06-22 08:00AMQorvo® to Present at the Goldman Sachs 2022 Communacopia + Technology Conference GlobeNewswire
Sep-02-22 11:31AMQorvo (QRVO) Down 17.1% Since Last Earnings Report: Can It Rebound? Zacks
Aug-30-22 08:15AM10 Best Cheap Semiconductor Stocks to Buy and Hold Insider Monkey
Aug-30-22 08:00AMQorvo® Appoints Grant Brown Chief Financial Officer GlobeNewswire
Aug-26-22 10:05AMQorvo (QRVO) GaN Pa Module Provides Highest Gains for L-Band Zacks
Aug-25-22 08:00AMQorvo® GaN PA Module Delivers Highest Gain for L-Band Applications GlobeNewswire
Aug-22-22 08:50AMEarnings grew faster than the notable 14% CAGR delivered to Qorvo (NASDAQ:QRVO) shareholders over the last three years Simply Wall St.
Aug-17-22 08:00AMQorvo® Drives Avionics and Radar Innovation with High Power RF GaN-on-SiC Pallet Solution GlobeNewswire
Aug-16-22 05:10AMThis Tech Stock May Plunge Sooner Than Later Following Its Impressive Rally Motley Fool
Aug-15-22 10:27AMChinas Real Estate Market Crash Can Affect These 10 American Stocks Insider Monkey
Qorvo, Inc. develops and commercializes technologies and products for wireless, wired, and power markets worldwide. The company operates through two segments, Mobile Products, and Infrastructure and Defense Products. It offers mobile devices, such as smartphones, wearables, laptops, tablets and other devices; radio frequency power management integrated circuits, ultra-wideband (UWB) system-on-a-chip (SoC) and system-in-package (SiP) solutions, MEMS-based sensors, antenna tuners, and antennaplexers, as well as discrete multiplexers, duplexers, filters, and switches; and cellular base stations include switch-low noise amplifier (LNA) modules, variable gain amplifiers, integrated power amplifier (PA) Doherty modules, discrete LNAs, and high power GaN amplifiers. The company's also provides SiC products, such as Schottky diodes and transistors for automotive, industrial, IT infrastructure and renewable energy markets; SoC hardware, firmware, and application software for smart home applications; power management solutions include programmable power management integrated circuits (ICs) and power application controllers; RF products and compound semiconductor foundry services to defense primes and other global defense and aerospace customers; RF connectivity and UWB SoC solutions for automotive connectivity; and Wi-Fi products, such as PAs, switches, LNAs and bulk acoustic wave filters, as well as integrated solutions including front end modules (FEMs) and integrated FEMs. It sells its products directly to original equipment manufacturers and original design manufacturers, as well as through a network of sales representative firms and distributors. The company was founded in 1957 and is headquartered in Greensboro, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GARDNER JEFFERY RDirectorSep 07Sale89.161,500133,74029,360Sep 07 04:30 PM
Stewart Frank P.VP, Advanced CellularAug 22Sale100.271,224122,7304,950Aug 24 04:18 PM
FEGO PAUL JVP, Global OperationsAug 15Sale110.182,438268,61934,079Aug 16 04:40 PM
Nelson RoderickDirectorJun 16Option Exercise13.624,76164,84510,356Jun 21 04:17 PM
Nelson RoderickDirectorJun 16Sale95.264,761453,5335,595Jun 21 04:17 PM
CompanyNovoCure Limited
IndustryMedical Instruments & Supplies
Market Cap8.69BEPS (ttm)-0.66
P/E-EPS this Y-819.30%
Forward P/E-EPS next Y-15.80%
PEG-EPS past 5Y18.20%
P/S15.94EPS next 5Y-
P/B19.64EPS Q/Q-62.20%
Dividend-Sales Q/Q5.50%
Insider Own1.20%Inst Own78.20%
Insider Trans-3.99%Inst Trans-0.92%
Short Float7.64%EarningsJul 28/b
Analyst Recom2.90Target Price94.25
Avg Volume583.56K52W Range56.39 - 143.69
Aug-31-22 08:00AMNovocure to Participate in Upcoming Investor Conferences Business Wire
Aug-22-22 10:15AMWhy I Own Novocure Stock (NVCR) Motley Fool
Aug-20-22 06:10AM3 Monster Stocks in the Making to Buy Right Now Motley Fool
Aug-10-22 08:00AMNovocure Hosts U.S. Sen. Maggie Hassan at Companys Portsmouth Facility Business Wire
Jul-31-22 09:30PM5 Top Stocks for August Motley Fool
Jul-28-22 03:30PMNovocure (NVCR) Q2 2022 Earnings Call Transcript Motley Fool
Jul-28-22 08:25AMNovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates Zacks
Jul-28-22 07:00AMNovocure Reports Second Quarter 2022 Financial Results Business Wire
Jul-27-22 08:00AMNovocure Announces Recipients of 4th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program Business Wire
Jul-23-22 05:58AM3 Beaten-Down Stocks That Could Soar in the Second Half of 2022 Motley Fool
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Leonard Frank XChief Development OfficerSep 06Sale78.571,384108,74186,013Sep 07 04:27 PM
Burke William PatrickChief Human Resources OfficerSep 02Sale79.0471856,74955,486Sep 06 05:16 PM
Cordova AshleyChief Financial OfficerSep 02Sale79.0488569,94872,376Sep 06 05:15 PM
GROENHUYSEN WILHELMUS CMChief Operating OfficerSep 02Sale79.0429623,395165,024Sep 06 05:14 PM
Shah PriteshChief Commercial OfficerSep 02Sale79.0426921,26183,230Sep 06 05:12 PM
CompanyXenon Pharmaceuticals Inc.
Market Cap2.37BEPS (ttm)-1.72
P/E-EPS this Y-117.90%
Forward P/E-EPS next Y-45.90%
PEG-EPS past 5Y-3.50%
P/S111.99EPS next 5Y-
P/B2.69EPS Q/Q-10.70%
Dividend-Sales Q/Q-77.30%
Insider Own0.10%Inst Own94.60%
Insider Trans-87.54%Inst Trans17.90%
Short Float3.80%EarningsAug 09/a
Analyst Recom1.50Target Price49.82
Avg Volume502.93K52W Range14.65 - 41.39
Sep-01-22 04:01PMXenon Pharmaceuticals to Present at the Wells Fargo 2022 Healthcare Conference GlobeNewswire
Aug-29-22 07:14PM10 Best Biotech Stocks To Buy Now Insider Monkey
Aug-15-22 07:24PMJ.P. Morgan Says the Stock Market Is Poised for More Upside; Here Are 2 Stocks the Banking Giant Likes TipRanks
Aug-12-22 07:40AMWhat Does The Future Hold For Xenon Pharmaceuticals Inc. (NASDAQ:XENE)? These Analysts Have Been Cutting Their Estimates Simply Wall St.
Aug-09-22 05:15PMXenon Pharmaceuticals (XENE) Reports Q2 Loss, Misses Revenue Estimates Zacks
Aug-09-22 04:01PMXenon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update GlobeNewswire
Aug-08-22 08:30AMXenon Pharmaceuticals to Present at the 13th Annual Wedbush PacGrow Healthcare Conference GlobeNewswire
Aug-02-22 04:01PMXenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Second Quarter 2022 Financial Results and Provide Corporate Update GlobeNewswire
Jul-22-22 06:20AMWhat Type Of Shareholders Own The Most Number of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares? Simply Wall St.
Jul-11-22 04:01PMXenon Pharmaceuticals to Present at the William Blair Biotech Focus Conference 2022 GlobeNewswire
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other potential indications, including adult focal epilepsy; and XEN007, A central nervous system-acting calcium channel modulator, which is in Phase II clinical trials. It has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy; and with Flexion Therapeutics, Inc. to develop PCRX301 (XEN402, a Nav1.7 inhibitor) for the treatment of post-operative pain. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AULIN SHERRYChief Financial OfficerSep 02Option Exercise6.9718,648130,06118,648Sep 07 04:26 PM
AULIN SHERRYChief Financial OfficerSep 02Sale39.5715,355607,5970Sep 07 04:26 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationSep 01Option Exercise4.7550,000237,50066,796Sep 02 04:27 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationSep 01Sale38.1843,8791,675,47616,796Sep 02 04:27 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationAug 31Option Exercise3.1322,48870,44339,720Sep 02 04:27 PM
CompanyOscar Health, Inc.
IndustryHealthcare Plans
Market Cap1.27BEPS (ttm)-2.86
P/E-EPS this Y-55.00%
Forward P/E-EPS next Y37.60%
PEG-EPS past 5Y-
P/S0.43EPS next 5Y34.00%
P/B0.97EPS Q/Q-50.20%
Dividend-Sales Q/Q92.20%
Insider Own0.50%Inst Own92.00%
Insider Trans-10.98%Inst Trans-0.48%
Short Float5.35%EarningsAug 11/a
Analyst Recom3.00Target Price7.64
Avg Volume1.86M52W Range3.89 - 18.89
Aug-23-22 12:18PMOscar and Cigna bringing their joint health insurance product for small businesses to Philadelphia American City Business Journals
Aug-16-22 09:49AMCigna (CI) & Oscar Health Boost Presence in Philadelphia Zacks
Aug-15-22 09:00AMCigna + Oscar Expands Footprint to Bring Small Businesses in Philadelphia Access to Cost-Effective Health Plans Business Wire
Aug-12-22 03:00AMOscar Health, Inc. (OSCR) Q2 2022 Earnings Call Transcript Motley Fool
Aug-11-22 04:05PMOscar Health Announces Results for Second Quarter 2022 Business Wire
Aug-04-22 07:15AMCigna (CI) Q2 Earnings and Revenues Beat Estimates Zacks
Aug-03-22 07:35PMTrean Insurance (TIG) Surpasses Q2 Earnings Estimates Zacks
Aug-01-22 05:45PMEverQuote (EVER) Reports Q2 Loss, Tops Revenue Estimates Zacks
Jul-08-22 10:05AMDo Institutions Own Oscar Health, Inc. (NYSE:OSCR) Shares? Simply Wall St.
Jul-07-22 09:30AMOscar Health, Inc. 2022 Second Quarter Conference Call Business Wire
Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Blackley Richard ScottChief Financial OfficerSep 06Sale5.5331,615174,951300,000Sep 07 04:23 PM
Quane Alessandrea C.EVP, Chief Insurance OfficerSep 06Sale5.5317,53297,019148,804Sep 07 04:22 PM
Quane Alessandrea C.EVP, Chief Insurance OfficerSep 02Sale5.852,94717,240135,086Sep 06 04:19 PM
Blackley Richard ScottChief Financial OfficerSep 02Sale5.852,20712,911269,115Sep 06 04:18 PM
Weaver DennisChief Clinical OfficerSep 02Sale5.851,5969,33722,564Sep 06 04:18 PM
TickerETR [NYSE, S&P 500]
CompanyEntergy Corporation
IndustryUtilities - Diversified
Market Cap24.41BEPS (ttm)6.04
P/E19.73EPS this Y-19.70%
Forward P/E17.65EPS next Y5.88%
PEG3.26EPS past 5Y29.90%
P/S1.98EPS next 5Y6.04%
P/B2.07EPS Q/Q-17.40%
Dividend3.39%Sales Q/Q20.30%
Insider Own0.40%Inst Own92.80%
Insider Trans-20.08%Inst Trans3.29%
Short Float1.82%EarningsAug 03/b
Analyst Recom2.10Target Price129.00
Avg Volume1.07M52W Range98.50 - 126.82
Sep-06-22 10:07AMDuke Energy (DUK) Begins Blue River Solar Facility Operations Zacks
Sep-06-22 09:15AMThe Zacks Analyst Blog Highlights NextEra Energy ,Atmos Energy, Entergy, The Southern and Alliant Energy Zacks
Sep-06-22 08:25AMReasons to Add NiSource (NI) to Your Portfolio Right Now Zacks
Sep-02-22 09:32AM5 Defensive Picks to Stay Safe in Volatile September Zacks
Sep-01-22 09:24AMThe Zacks Analyst Blog Highlights Entergy, Icahn Enterprises, The Southern, NiSource and National Retail Properties Zacks
Sep-01-22 06:54AMDuke Energy (DUK) Achieves 700 MW of Solar Pledge in Florida Zacks
Aug-31-22 08:19AM5 Low-Beta High-Yielding Stocks for a Likely Volatile September Zacks
Aug-30-22 09:40AMHas Companhia Paranaense de Energia COPEL (ELP) Outpaced Other Utilities Stocks This Year? Zacks
Aug-25-22 11:40AMETR vs. DTE: Which Stock Is the Better Value Option? Zacks
Aug-24-22 12:54PMCleveland Electric Illuminating Company (The) -- Moody's announces completion of a periodic review for a group of North American Utilities issuers Moody's
Entergy Corporation, together with its subsidiaries, engages in the production and retail distribution of electricity in the United States. The company operates in two segments, Utility and Entergy Wholesale Commodities. The Utility segment generates, transmits, distributes, and sells electric power in portions of Arkansas, Louisiana, Mississippi, and Texas, including the City of New Orleans; and distributes natural gas. The Entergy Wholesale Commodities segment engages in the ownership, operation, and decommissioning of nuclear power plants; and ownership of interests in non-nuclear power plants that sell electric power to wholesale customers, as well as provides services to other nuclear power plant owners. It generates electricity through gas, nuclear, coal, hydro, and solar power sources. The company sells energy to retail power providers, utilities, electric power co-operatives, power trading organizations, and other power generation companies. The company's power plants have approximately 26,000 megawatts (MW) of electric generating capacity, which include 6,000 MW of nuclear power. It delivers electricity to 3 million utility customers in Arkansas, Louisiana, Mississippi, and Texas. The company was founded in 1913 and is headquartered in New Orleans, Louisiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HERMAN ALEXIS MDirectorSep 06Sale116.5619022,1467,379Sep 07 04:18 PM
HERMAN ALEXIS MDirectorAug 18Sale120.3516119,3767,375Aug 19 04:19 PM
HINNENKAMP PAUL DEVP & Chief Operating OfficerMay 27Option Exercise70.536,500458,44532,602Jun 01 06:13 PM
HINNENKAMP PAUL DEVP & Chief Operating OfficerMay 27Sale120.946,500786,11026,102Jun 01 06:13 PM
RODRIGUEZ DEANNA D."Officer" Under Sec. 16 RulesApr 29Sale120.2225630,7763,108May 02 05:38 PM
CompanyAlector, Inc.
Market Cap911.31MEPS (ttm)0.48
P/E22.33EPS this Y81.50%
Forward P/E-EPS next Y-2.00%
PEG-EPS past 5Y-15.40%
P/S3.03EPS next 5Y-
P/B3.06EPS Q/Q119.10%
Dividend-Sales Q/Q495.50%
Insider Own4.10%Inst Own80.50%
Insider Trans-0.07%Inst Trans-2.62%
Short Float7.39%Earnings-
Analyst Recom1.90Target Price24.22
Avg Volume519.12K52W Range7.50 - 27.05
Sep-07-22 07:00AMAlector to Participate in Upcoming Healthcare Conferences GlobeNewswire
Aug-09-22 09:55AMWall Street Analysts Believe Alector (ALEC) Could Rally 58%: Here's is How to Trade Zacks
Aug-06-22 08:33AMAlector, Inc.'s (NASDAQ:ALEC) Stock Is Going Strong: Have Financials A Role To Play? Simply Wall St.
Aug-04-22 07:15PMAlector (ALEC) Q2 Earnings and Revenues Beat Estimates Zacks
Aug-04-22 04:05PMAlector Reports Second Quarter 2022 Financial Results and Provides Business Update GlobeNewswire
Jul-08-22 10:54AMAbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector Benzinga
Jul-07-22 05:59PMAlzheimer's drug cut loose from Peninsula biotech's collaboration but another survives American City Business Journals
Jun-08-22 07:00AMAlector to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference GlobeNewswire
May-28-22 08:20AMShareholders in Alector (NASDAQ:ALEC) are in the red if they invested a year ago Simply Wall St.
May-27-22 04:30PMAlector Reports Inducement Grants as permitted by the Nasdaq Listing Rules GlobeNewswire
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase I clinical trial for the treatment of Alzheimer's disease. In addition, its products in development stage include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies; and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies, such as AL001 and AL101 to treat neurodegenerative diseases. The company was founded in 2013 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
King RobertChief Development OfficerSep 02Sale10.621761,869529,295Sep 07 04:15 PM
Romano GaryChief Medical OfficerSep 02Sale10.622,17723,12090,073Sep 07 04:17 PM
King RobertChief Development OfficerJun 02Sale8.711771,542529,471Jun 06 04:52 PM
King RobertChief Development OfficerMar 01Sale15.572874,468528,404Mar 03 05:41 PM
SULIMAN SHEHNAAZPresident and COODec 13Option Exercise17.2375,0001,292,250177,598Dec 14 08:23 PM
TickerZI [NASD]
CompanyZoomInfo Technologies Inc.
IndustrySoftware - Application
Market Cap17.67BEPS (ttm)0.03
P/E1640.77EPS this Y372.90%
Forward P/E41.02EPS next Y30.49%
PEG45.99EPS past 5Y-
P/S19.02EPS next 5Y35.67%
P/B8.05EPS Q/Q-19.20%
Dividend-Sales Q/Q53.50%
Insider Own7.30%Inst Own93.80%
Insider Trans-21.16%Inst Trans7.48%
Short Float4.71%EarningsAug 01/a
Analyst Recom1.80Target Price64.57
Avg Volume4.34M52W Range30.31 - 79.17
Aug-30-22 09:00AMZoomInfo Provides Technology Usage Insights for More Than 30 Million Companies Business Wire
Aug-24-22 05:28PMZoomInfo CEO Henry Schuck on why the $928M company raised its guidance American City Business Journals
Aug-16-22 09:00AMZoomInfo Increases Company Data Coverage to More Than 100 Million Businesses Business Wire
Aug-03-22 09:00AMZoomInfo to Participate in Upcoming Investor Conferences Business Wire
Aug-02-22 12:27PMWhy ZoomInfo Stock Popped Today Motley Fool
Aug-01-22 11:30PMZoomInfo Technologies Inc. (ZI) Q2 2022 Earnings Call Transcript Motley Fool
Aug-01-22 06:11PMAfter-hours movers: Pinterest, Activision Blizzard, Avis Budget Group, ZoomInfo Yahoo Finance
Aug-01-22 05:35PMZoomInfo (ZI) Q2 Earnings and Revenues Surpass Estimates Zacks
Aug-01-22 05:29PMZoomInfo Stock Soars As Earnings, Revenue Top Estimates Investor's Business Daily
Aug-01-22 05:19PMStocks moving in after hours: Activision Blizzard, Pinterest, ZoomInfo, Avis Yahoo Finance Video
ZoomInfo Technologies Inc., through its subsidiaries, provides go-to-market intelligence and engagement platform for sales and marketing teams in the United States and internationally. The company's cloud-based platform provides information on organizations and professionals to help users identify target customers and decision makers, obtain continually updated predictive lead and company scoring, monitor buying signals and other attributes of target companies, craft messages, engage through automated sales tools, and track progress through the deal cycle. It serves enterprises, mid-market companies, and down to small businesses that operate in various industry verticals, including software, business services, manufacturing, telecommunications, financial services, media and internet, transportation, education, hospitality, and real estate. ZoomInfo Technologies Inc. was founded in 2007 and is headquartered in Vancouver, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hyzer Peter CameronChief Financial OfficerSep 07Sale41.505,000207,5001,147,531Sep 07 04:16 PM
Hays Joseph ChristopherPres, Chief Operating OfficerSep 02Sale41.642,526105,174595,126Sep 06 04:36 PM
Hays Joseph ChristopherPres, Chief Operating OfficerSep 01Sale42.4622,542957,235597,652Sep 06 04:36 PM
Keren NirPresident, Israel and CTOAug 31Sale45.1815,000677,7611,054,505Sep 01 05:30 PM
Carlyle Group Inc.Former 10% ownerAug 15Sale50.85167,7558,529,53440,307,862Aug 17 06:45 PM
CompanyAgileThought, Inc.
IndustrySoftware - Application
Market Cap193.89MEPS (ttm)-0.55
P/E-EPS this Y13.80%
Forward P/E-EPS next Y28.60%
PEG-EPS past 5Y-
P/S1.17EPS next 5Y-
P/B2.11EPS Q/Q-23.30%
Dividend-Sales Q/Q18.80%
Insider Own2.70%Inst Own51.70%
Insider Trans-5.25%Inst Trans4.53%
Short Float0.85%EarningsAug 11/a
Analyst Recom1.50Target Price8.00
Avg Volume30.51K52W Range3.95 - 16.48
Aug-11-22 04:07PMAgileThought Reports Second Quarter 2022 Financial Results GlobeNewswire
Aug-04-22 08:00AMAgileThought to Report Second Quarter 2022 Financial Results on August 11, 2022 GlobeNewswire
Jul-15-22 08:30AMWhat Kind Of Shareholders Hold The Majority In AgileThought, Inc.'s (NASDAQ:AGIL) Shares? Simply Wall St.
Jul-08-22 08:33AMAgileThought and ExperienceIT Join Forces to Accelerate Digital Transformation for Clients Through Integrated Delivery Squads GlobeNewswire
Jun-30-22 08:00AMAgileThought Names Gonzalo Mones Cazon as Chief People Officer GlobeNewswire
Jun-15-22 07:47AMEstimating The Fair Value Of AgileThought, Inc. (NASDAQ:AGIL) Simply Wall St.
Jun-09-22 08:00AMAgileThought Announces the Launch of Eight Technology Guilds to Enable Businesses to Accelerate Digital Transformation GlobeNewswire
May-12-22 04:05PMAgileThought Reports First Quarter 2022 Financial Results GlobeNewswire
May-06-22 08:00AMAgileThought to Report First Quarter 2022 Financial Results on May 12, 2022 GlobeNewswire
May-02-22 08:00AMAgileThought Names Industry Veteran Amit Singh as Chief Financial Officer GlobeNewswire
AgileThought, Inc. provides digital transformation services in the United States and Latin America. It offers product management services comprising AgileIgnite and DevOpsIgnite; user experience, application engineering, modernization and mobility, advanced data analytics, cloud architecture and migration, automation, and artificial intelligence and machine learning services. The company also provides DevOps and application optimization, and lifecycle management support services. It serves healthcare, professional services, financial services, consumer packaged goods, retail, and industrial services industries. AgileThought, Inc. was founded in 2000 and is headquartered in Irving, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Elizondo Mauricio Garduno GonzVP, Business DevelopmentSep 02Sale4.159,51739,505929,774Sep 07 04:15 PM
Elizondo Mauricio Garduno GonzVP, Business DevelopmentSep 01Sale4.1618,49676,851939,291Sep 02 04:15 PM
Elizondo Mauricio Garduno GonzVP, Business DevelopmentAug 31Sale4.2112,53652,814957,787Sep 02 04:15 PM
Elizondo Mauricio Garduno GonzVP, Business DevelopmentAug 30Sale4.305,64324,282970,323Aug 31 08:38 PM
Elizondo Mauricio Garduno GonzVP, Business DevelopmentAug 29Sale4.3324,550106,375975,966Aug 31 08:38 PM
TickerTW [NASD]
CompanyTradeweb Markets Inc.
IndustryCapital Markets
Market Cap15.88BEPS (ttm)1.23
P/E53.66EPS this Y23.90%
Forward P/E31.40EPS next Y12.50%
PEG4.17EPS past 5Y21.20%
P/S13.80EPS next 5Y12.85%
P/B2.86EPS Q/Q23.70%
Dividend0.49%Sales Q/Q13.90%
Insider Own0.10%Inst Own-
Insider Trans-66.42%Inst Trans0.66%
Short Float2.61%EarningsAug 03/b
Analyst Recom2.30Target Price83.80
Avg Volume688.85K52W Range59.82 - 102.33
Sep-07-22 07:30AMTradeweb Reports Total August Trading Volume of $23.4 Trillion With 13.0% YoY Increase in Average Daily Volume Business Wire
Sep-01-22 04:48AMEuropean negative-yielding govt bond pile shrinks to new low - Tradeweb Reuters
Aug-22-22 09:25AMUPDATE 1-Kenya's bonds fall after Odinga formally challenges election results - Tradeweb data Reuters
Aug-22-22 07:38AMKenya's bonds fall after Odinga formally challenges election results - Tradeweb data Reuters
Aug-04-22 02:34PMTumultuous Era for TIPS Accommodates More Electronic Cash Flows Bloomberg
Aug-03-22 08:00PMTradeweb Markets Inc (TW) Q2 2022 Earnings Call Transcript Motley Fool
Aug-03-22 08:15AMTradeweb Markets (TW) Q2 Earnings Beat Estimates Zacks
Aug-03-22 07:00AMTradeweb Reports Second Quarter 2022 Financial Results Business Wire
Aug-03-22 06:30AMTradeweb Reports Trading Volume of $22.0 Trillion in July with 12.0% YoY Increase in Average Daily Volume Business Wire
Aug-01-22 09:09AMUPDATE 1-European negative-yielding govt bond pool shrinks below 9% of market Reuters
Tradeweb Markets Inc. builds and operates electronic marketplaces in the Americas, Europe, the Middle East, Africa, Asia Pacific, and internationally. The company's marketplaces facilitate trading in a range of asset classes, including rates, credit, money markets, and equities. It offers pre-trade data and analytics, trade execution, and trade processing, as well as post-trade data, analytics, and reporting services. The company provides flexible order and trading systems to institutional investors in 45 markets across 25 currencies. It also offers a range of electronic, voice, and hybrid platforms to approximately 300 dealers and financial institutions on electronic or hybrid markets with Dealerweb platform; and trading solutions for financial advisory firms and traders with Tradeweb Direct platform. The company serves a network of approximately 2,500 clients in the institutional, wholesale, and retail client sectors. Its customers include asset managers, hedge funds, insurance companies, central banks, banks and dealers, proprietary trading firms, retail brokerage and financial advisory firms, and regional dealers. Tradeweb Markets Inc. was founded in 1996 and is headquartered in New York, New York. Tradeweb Markets Inc. is a subsidiary of Refinitiv Parent Limited.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BERNS STEVENDirectorSep 06Sale66.893,503234,3161,125Sep 07 04:15 PM
Olesky LeeChief Executive OfficerAug 18Sale74.5817,1191,276,742230,164Aug 18 09:14 PM
Olesky LeeChief Executive OfficerAug 17Sale74.513,094230,524247,283Aug 18 09:14 PM
Olesky LeeChief Executive OfficerAug 16Option Exercise20.5951,4681,059,726301,845Aug 16 08:42 PM
Olesky LeeChief Executive OfficerAug 16Sale74.0651,4683,811,525250,377Aug 16 08:42 PM